Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 33376 - 33400 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Calcitriol	Approved Investigational Nutraceutical	GAS1	2619	downregulated	Calcitriol results in decreased expression of GAS1 mRNA	9q21.33	A22299
Calcitriol	Approved Investigational Nutraceutical	GAS2L3	283431	downregulated	Calcitriol results in decreased expression of GAS2L3 mRNA	12q23.1	A22301
Calcitriol	Approved Investigational Nutraceutical	GAS7	8522	downregulated	Calcitriol results in decreased expression of GAS7 mRNA	17p13.1	A22299
Calcitriol	Approved Investigational Nutraceutical	GATA2	2624	upregulated	Calcitriol results in increased expression of GATA2 mRNA	3q21.3	A22300
Calcitriol	Approved Investigational Nutraceutical	GATA3	2625	upregulated	Calcitriol results in increased expression of GATA3 mRNA	10p14	A22299
Calcitriol	Approved Investigational Nutraceutical	GBP1	2633	upregulated	Calcitriol results in increased expression of GBP1 mRNA	1p22.2	A22301
Calcitriol	Approved Investigational Nutraceutical	GBP2	2634	upregulated	Calcitriol results in increased expression of GBP2 mRNA	1p22.2	A22301
Calcitriol	Approved Investigational Nutraceutical	GBP3	2635	upregulated	Calcitriol results in increased expression of GBP3 mRNA	1p22.2	A22301
Calcitriol	Approved Investigational Nutraceutical	GCNT1	2650	downregulated	Calcitriol results in decreased expression of GCNT1 mRNA	9q21.13	A22300
Calcitriol	Approved Investigational Nutraceutical	GCNT3	9245	upregulated	Calcitriol results in increased expression of GCNT3 mRNA	15q22.2	A22300
Calcitriol	Approved Investigational Nutraceutical	GDF15	9518	upregulated	Calcitriol results in increased expression of GDF15 mRNA	19p13.11	A22358 A20578
Calcitriol	Approved Investigational Nutraceutical	GDPD3	79153	upregulated	Calcitriol results in increased expression of GDPD3 mRNA	16p11.2	A22301
Calcitriol	Approved Investigational Nutraceutical	GEM	2669	upregulated	Calcitriol results in increased expression of GEM mRNA	8q22.1	A22311 A22300
Calcitriol	Approved Investigational Nutraceutical	GEMIN2	8487	downregulated	Calcitriol results in decreased expression of GEMIN2 mRNA	14q21.1	A22301
Calcitriol	Approved Investigational Nutraceutical	GEMIN4	50628	downregulated	Calcitriol results in decreased expression of GEMIN4 mRNA	17p13.3	A22301
Calcitriol	Approved Investigational Nutraceutical	GEN1	348654	downregulated	Calcitriol results in decreased expression of GEN1 mRNA	2p24.2	A22301
Calcitriol	Approved Investigational Nutraceutical	GFPT2	9945	downregulated	Calcitriol results in decreased expression of GFPT2 mRNA	5q35.3	A22299
Calcitriol	Approved Investigational Nutraceutical	GGH	8836	downregulated	Calcitriol results in decreased expression of GGH mRNA	8q12.3	A22301
Calcitriol	Approved Investigational Nutraceutical	GGTLC1	92086	upregulated	Calcitriol results in increased expression of GGTLC1 mRNA	20p11.21	A22301
Calcitriol	Approved Investigational Nutraceutical	GGTLC2	91227	upregulated	Calcitriol results in increased expression of GGTLC2 mRNA	22q11.22	A22301
Calcitriol	Approved Investigational Nutraceutical	GIMAP2	26157	upregulated	Calcitriol results in increased expression of GIMAP2 mRNA	7q36.1	A22300
Calcitriol	Approved Investigational Nutraceutical	GIMAP8	155038	upregulated	Calcitriol results in increased expression of GIMAP8 mRNA	7q36.1	A22300
Calcitriol	Approved Investigational Nutraceutical	GINS1	9837	downregulated	Calcitriol results in decreased expression of GINS1 mRNA	20p11.21	A22301
Calcitriol	Approved Investigational Nutraceutical	GINS2	51659	downregulated	Calcitriol results in decreased expression of GINS2 mRNA	16q24.1	A22301
Calcitriol	Approved Investigational Nutraceutical	GINS3	64785	downregulated	Calcitriol results in decreased expression of GINS3 mRNA	16q21	A22301

Displaying entries 33376 - 33400 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability